A look at BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) from another angle


How far has the stock of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) come to trade at their current price of $6.73, which gives it a market cap of $579.79M.

To trade now at $6.73, the stock has emerged from a 52-week low of $158.85%. But the current price also compares with the 52-week peak of $-27.24%.

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction. Longer term, the trend strength is Weak.

The stock’s journey to the current price can be understood by looking at its performance from the last week down to the 12 months. The stock’s weekly performance stands at 14.65% and its monthly performance is 6.32%%. For the quarter, the stock has moved 22.59% and for half-year it has shifted 14.07%. So far this year the stock has moved 100.90% and for the last 12 months it has moved 6.32%.

Studying simple moving averages also tell the stock?s journey thus far. The 20-Day Simple Moving Average is $15.47%, the 50-Day Simple Moving Average is $-3.39%, while the 200-Day Simple Moving Average is $15.48%.

In terms of financial performance, BioCryst Pharmaceuticals, Inc. reported gross margin of 92.60% for the trailing 12 months.

BioCryst Pharmaceuticals, Inc.’s P/Cash for the most recent quarter is 5.87, while P/Free Cash Flow for the trailing 12 months is -. Dividend yield and payout ratio calculate to – and -. For perspective, payout ratio provides insight into a company’s ability to sustain dividend distributions. As such, a lower payout ratio is preferred to a higher payout ratio is it implies a company is preserving more cash for investments and other needs that it releases to shareholders.